Avita Medical announces interim results from Cohealyx-I multi-center study

Avita Medical (RCEL) announced interim results from its Cohealyx-I multi-center study demonstrating a reduction of nearly 20 days in mean time to skin grafting for patients with full-thickness wounds. The results demonstrated statistical superiority versus a literature-derived benchmark, based on the lower bound of the 95% confidence interval. The benchmark was derived from a meta-analysis of published data on leading dermal matrices, representing approximately 900 patients. The interim analysis of 40 patients showed a median time to grafting of 11 days. Grafting was achieved as early as five days, with 25% grafted within seven days, and 72% grafted within 14 days. Investigators reported 90% satisfaction at the time of grafting, including among predominantly first-time users, supporting consistent performance and potential for broader adoption in clinical practice.